BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27835727)

  • 21. Caution urged in interpreting a negative study of cannabis use and schizophrenia.
    Miller CL
    Schizophr Res; 2014 Apr; 154(1-3):119-20. PubMed ID: 24636304
    [No Abstract]   [Full Text] [Related]  

  • 22. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
    Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
    Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
    Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
    Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units].
    Chrostek Maj J; Kroch S; Kamenczak A; Polewka A; Szerszeń-Motyka J
    Przegl Lek; 2004; 61(4):317-9. PubMed ID: 15521592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of cannabis use on the clinical condition of schizophrenics.
    Negrete JC; Knapp WP
    NIDA Res Monogr; 1986; 67():321-7. PubMed ID: 3092086
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurocognitive functions of heavy cannabis using schizophrenia patients.
    Lev-Ran S; Segev A; Braw Y; Levkovitz Y
    Eur Psychiatry; 2012 Jul; 27(5):365-8. PubMed ID: 21704501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.
    Mueser KT; Yarnold PR; Levinson DF; Singh H; Bellack AS; Kee K; Morrison RL; Yadalam KG
    Schizophr Bull; 1990; 16(1):31-56. PubMed ID: 2333480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia.
    Rentzsch J; Stadtmann A; Montag C; Kunte H; Plöckl D; Hellweg R; Gallinat J; Kronenberg G; Jockers-Scherübl MC
    Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):409-21. PubMed ID: 26182894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).
    Helle S; Ringen PA; Melle I; Larsen TK; Gjestad R; Johnsen E; Lagerberg TV; Andreassen OA; Kroken RA; Joa I; Ten Velden Hegelstad W; Løberg EM
    Schizophr Res; 2016 Jan; 170(1):217-21. PubMed ID: 26682958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial.
    Smeerdijk M; Keet R; Dekker N; van Raaij B; Krikke M; Koeter M; de Haan L; Barrowclough C; Schippers G; Linszen D
    Psychol Med; 2012 Aug; 42(8):1627-36. PubMed ID: 22152121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric effects of cannabis.
    Johns A
    Br J Psychiatry; 2001 Feb; 178():116-22. PubMed ID: 11157424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.
    Rabin RA; Barr MS; Goodman MS; Herman Y; Zakzanis KK; Kish SJ; Kiang M; Remington G; George TP
    Neuropsychopharmacology; 2017 Oct; 42(11):2259-2271. PubMed ID: 28443616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is cannabis a vulnerability factor in schizophrenic disorders].
    Laqueille X
    Arch Pediatr; 2009 Sep; 16(9):1302-5. PubMed ID: 19640690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
    Kirkpatrick B; Amador XF; Flaum M; Yale SA; Gorman JM; Carpenter WT; Tohen M; McGlashan T
    Schizophr Res; 1996 May; 20(1-2):69-77. PubMed ID: 8794495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis abuse and the course of recent-onset schizophrenic disorders.
    Linszen DH; Dingemans PM; Lenior ME
    Arch Gen Psychiatry; 1994 Apr; 51(4):273-9. PubMed ID: 8161287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re: Caution urged in interpreting a negative study of cannabis use and schizophrenia: a response to Dr. Christine Miller.
    Delisi LE
    Schizophr Res; 2014 Apr; 154(1-3):121. PubMed ID: 24630137
    [No Abstract]   [Full Text] [Related]  

  • 38. [Does cannabis use lead to schizophrenia?].
    Heekeren K
    Praxis (Bern 1994); 2011 Nov; 100(22):1361-7. PubMed ID: 22048912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study.
    Sigmon SC; Steingard S; Badger GJ; Anthony SL; Higgins ST
    Exp Clin Psychopharmacol; 2000 Nov; 8(4):509-17. PubMed ID: 11127422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tobacco, alcohol and cannabis use in Tunisian patients with schizophrenia.
    Laqueille X; Ghodhbane S; Nacef F; Choubani Z; Nehdi M; Douki S; Dervaux A
    Schizophr Res; 2008 Jan; 98(1-3):327-8. PubMed ID: 17689929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.